Class II haplotype differentially regulates immune response in HgCl2- treated mice

Clinical Immunology and Immunopathology

Volumn 84, Issue 3, 1997, Pages 328-337

  Hanley, Gregory A ^a   Schiffenbauer, Joel ^b   Sobel, Eric S ^b  

^a University of Florida College of Veterinary Medicine   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FIBRILLARIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MERCURY CHLORIDE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; DISEASE PREDISPOSITION; ETIOLOGY; GENE EXPRESSION; HAPLOTYPE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031240035     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4405     Document Type: Article

References (35)

1. Goldman M., Druet P., Gleichmann E. TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today. 12:1991;223-227.
2. Hultman P., Enestrom S. Mercury induced antinuclear antibodies in mice: Characterization and correlation with renal immune complex deposits. Clin. Exp. Immunol. 71:1988;269-274.
3. Pietsch P., Vohr H. W., Degitz K., Gleichmann E. Immunological alterations inducible by mercury compounds. II. HgCl2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int. Arch. Allergy Appl. Immunol. 90:1989;47-53.
4. Hultman P., Enestrom S. Mercury induced B-cell activation and antinuclear antibodies in mice. J. Clin. Lab. Immunol. 28:1989;143-150.
5. Robinson C. J., Abraham A. A., Balazs T. Induction of anti-nuclear antibodies by mercuric chloride in mice. Clin. Exp. Immunol. 58:1984;300-306.
6. Kass S., Tyc K., Steitz J. A., Sollner Webb B. The U3 small nucleolar ribonucleoprotein functions in the first step of preribosomal RNA processing. Cell. 60:1990;897-908.
7. Reuter R., Tessars G., Vohr H. W., Gleichmann E., Luhrmann R. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc. Natl. Acad. Sci. USA. 86:1989;237-241.
8. Okano Y., Steen V. D., Medsger T. A. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum. 35:1992;95-100.
9. Kasturi K. N., Hatakeyama A., Spiera H., Bona C. A. Antifibrillarin autoantibodies present in systemic sclerosis and other connective tissue diseases interact with similar epitopes. J. Exp. Med. 181:1995;1027-1036.
10. Lubben B., Rottmann N., Kubicka Muranyi M., Gleichmann E., Luhrmann R. The specificity of disease-associated anti-fibrillarin autoantibodies compared with that of HgCl2-induced autoantibodies. Mol. Biol. Rep. 20:1994;63-73.
11. Bencko V., Wagner V., Wagnerova M., Ondrejcak V. Immunological profiles in workers occupationally exposed to inorganic mercury. J. Hyg. Epidemiol. Microbiol. Immunol. 34:1990;9-15.
12. Tubbs R. R., Gephardt G. N., McMahon J. T., Pohl M. C., Vidt D. G., Barenberg S. A., Valenzuela R. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am. J. Clin. Pathol. 77:1982;409-413.
13. Robinson C. J., Balazs T., Egorov I. K. Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice. Toxicol. Appl. Pharmacol. 86:1986;159-169.
14. Hultman P., Turley S. J., Enestrom S., Lindh U., Pollard K. M. Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity. J. Autoimmunity. 9:1996;139-149.
15. Mirtcheva J., Pfeiffer C., De Bruijn J. A., Jacquesmart F., Gleichmann E. Immunological alterations inducible by mercury compounds. III. H-2A acts as an immune response and H-2E as an immune "suppression" locus for HgCl2-induced antinucleolar autoantibodies. Eur. J. Immunol. 19:1989;2257-2261.
16. Hultman P., Bell L. J., Enestrom S., Pollard K. M. Murine susceptibility to mercury. I. Autoantibody profiles and systemic immune deposits in inbred, congenic, and intra-H-2 recombinant strains. Clin. Immunol. Immunopathol. 65:1992;98-109.
17. Stiller Winkler R., Radaszkiewicz T., Gleichmann E. Immunopathological signs in mice treated with mercury compounds. I. Identification by the popliteal lymph node assay of responder and nonresponder strains. Int. J. Immunopharmacol. 10:1988;475-484.
18. Hultman P., Bell L. J., Enestrom S., Pollard K. M. Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin. Immunol. Immunopathol. 68:1993;9-20.
19. Walter W., Loos M., Maeurer M. J. H2-M polymorphism in mice susceptible to collagen-induced arthritis involves the peptide binding groove. Immunogenetics. 44:1996;19-26.
20. Widera G., Burkly L. C., Pinkert C. A., Bottger E. C., Cowing C., Palmiter R. D., Brinster R. L., Flavell R. A. Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: An in vivo approach to investigate Ia gene function. Cell. 51:1987;175-187.
21. Grusby M. J., Johnson R. S., Papaioannou V. E., Glimcher L. H. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 253:1991;1417-1420.
22. Merino R., Iwamoto M., Fossati L., Muniesa P., Araki K., Takahashi S., Huarte J., Yamamura K., Vassalli J. D., Izui S. Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain. J. Exp. Med. 178:1993;1189-1197.
23. Creech E. A., Nakul Aquaronne D., Reap E. A., Cheek R. L., Wolthusen P. A., Cohen P. L., Eisenberg R. A. MHC genes modify systemic autoimmune disease. The role of the I-E locus. J. Immunol. 156:1996;812-817.
24. Kappler J. W., Skidmore B., White J., Marrack P., Antigen-inducible H-. 2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1981;1198-1214.
25. Ozato K., Mayer N., Sachs D. H. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:1980;533-540.
26. Morris S. C., Cheek R. L., Cohen P. L., Eisenberg R. A. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171:1990;503-517.
27. Aris J. P., Blobel G. Identification and characterization of a yeast nucleolar protein that is similar to a rat liver nucleolar protein. J. Cell Biol. 107:1988;17-31.
28. O'Shannessy D. J., Dobersen M. J., Quarles R. H. A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties. Immunol. Lett. 8:1984;273-277.
29. Goding J. W. Conjugation of antibodies with fluorochromes: Modifications to the standard methods. J. Immunol. Methods. 13:1976;215-226.
30. Ceman S., Rudersdorf R. A., Petersen J. M., DeMars R. DMA and DMB are the only genes in the class II region of the human MHC needed for class II-associated antigen processing. J. Immunol. 154:1995;2545-2556.
31. Riberdy J. M., Cresswell P. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation [published erratum appears in J Immunol 1992 Aug 1; 149(3):1113]. J. Immunol. 148:1992;2586-2590.
32. Hill S. W., Kipp D. E., Melchers I., Frelinger J. A., Sercarz E. E. Multiple H-2 and non-H-2 genes controlling the antilysozyme response: Alternative gene constellations can lead to responsiveness. Eur. J. Immunol. 10:1980;384-391.
33. Martin J., Wei B. Y., David C. S. Expression of MHC class II A alpha k transgene. Pairing with endogenous beta-chain is dependent upon affinity and competition. Transplantation. 56:1993;1233-1236.
34. Layet C., Germain R. N. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. USA. 88:1991;2346-2350.
35. Mathis D. J., Benoist C., Williams V. E., Kanter M., McDevitt H. O. Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. Proc. Natl. Acad. Sci. USA. 80:1983;273-277.